Matches in Nanopublications for { ?s ?p "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 9 of
9
with 100 items per page.
- NP198728.RAaKxG2-AolNI-wsl4Oz7lGAfO4Pv1e9vS8c6Gu0kmVss130_assertion description "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP198728.RAaKxG2-AolNI-wsl4Oz7lGAfO4Pv1e9vS8c6Gu0kmVss130_provenance.
- NP618661.RAWwhvXCIUvryAwlrm0jb1HP522TwixOR2AEfYZZYk4qU130_assertion description "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618661.RAWwhvXCIUvryAwlrm0jb1HP522TwixOR2AEfYZZYk4qU130_provenance.
- NP618662.RAdxz-jynPYIp1PxvW0tIman0tvZtmh0XMTpFzCG1j80c130_assertion description "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618662.RAdxz-jynPYIp1PxvW0tIman0tvZtmh0XMTpFzCG1j80c130_provenance.
- NP618669.RAfIMIeSkRjdVug9K5rLbQDEFvj8wSs5X3ypDi27pzE0w130_assertion description "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618669.RAfIMIeSkRjdVug9K5rLbQDEFvj8wSs5X3ypDi27pzE0w130_provenance.
- NP618665.RAkMzp_QMsuYVrFQBUKyl8JJ5B_c2lr1ngeFZBH273M5E130_assertion description "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618665.RAkMzp_QMsuYVrFQBUKyl8JJ5B_c2lr1ngeFZBH273M5E130_provenance.
- NP618667.RAn697GXhB9XTbbBIyBU8cMrKICGOcbUy10uwoiKXtSqo130_assertion description "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618667.RAn697GXhB9XTbbBIyBU8cMrKICGOcbUy10uwoiKXtSqo130_provenance.
- NP618666.RAFlD5R4hjP5hmNHlITbcTr9z9em9rS219Qc04ArOcwsY130_assertion description "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618666.RAFlD5R4hjP5hmNHlITbcTr9z9em9rS219Qc04ArOcwsY130_provenance.
- NP618664.RAxpm3V2pwim8OnlhzuezypT2T9ULvImh7ghbsoINKUkw130_assertion description "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618664.RAxpm3V2pwim8OnlhzuezypT2T9ULvImh7ghbsoINKUkw130_provenance.
- NP618668.RA3eyxPTXZwjVns6j73p5B5SAjHiZd128o4eHodU8gDU8130_assertion description "[Use of selective COX-2 inhibitors resulted in a significant risk reduction for each type of cancer (71% for breast cancer, 55% for prostate cancer, 70% for colon cancer, and 79% for lung cancer) and an overall 68% risk reduction for all four cancers.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP618668.RA3eyxPTXZwjVns6j73p5B5SAjHiZd128o4eHodU8gDU8130_provenance.